-
Global Nerve Repair & Regeneration Market Overview:
“The global Nerve Repair & Regeneration Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
The complex, and delicate structures that make up the nervous system, the brain, spinal cord, and peripheral nerves-are susceptible to various types of injury ranging from trauma to neurodegenerative diseases. Peripheral nerves link the brain and spinal cord to other parts of your body, such as muscles, and skin.
Moreover, damaged nerves can interfere with the brain's ability to communicate with muscles, and organs. Nerve repair & regeneration offers replacement of damaged nervous tissue, cells, and cellular products. Moreover, the nerve repair & regeneration mechanism involves generation of new axons, myelin, neurons, glial cells, and synapses.
Increase in geriatric population, and increasing incidence of neurological diseases across the globe are key factors driving growth of the global nerve repair & regeneration market. In addition, technological advancements in nerve repair, positive reimbursement policies, increasing investment from government in both developing, and developed countries on providing better healthcare facilities are major factors contributing to growth of the global nerve repair & regeneration market.
However, lack of awareness among patients about nerve repair & regeneration is a major factor restraining the growth of the global nerve repair & regeneration market. In addition, stringent regulations for product approvals internationally, and lack of skilled professionals for nerve repair & regeneration treatments are major factors effecting the growth of the global nerve repair & regeneration market.
The global nerve repair & regeneration market report has been segmented on the basis of surgery, product, and region. On the basis of the surgery, the global nerve repair & regeneration market is segmented into Direct Neuropathy, Nerve Grafting, Stem Cell Therapy, and Neuromodulation Surgery. On the basis of product into, Biomaterials, and Neuromodulation surgery devices. On the basis of region, into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America is expected to account for largest market share in terms of revenue as compared to that of markets in other regions. This is attributed to well-developed healthcare industry, presence of leading medical diagnostics manufacturers, and rise in number of patients suffering from neurological disorders. Europe is expected to account for second largest revenue share contribution to the global nerve repair & regeneration market followed by Asia Pacific.
The market in Asia Pacific is projected to have the fastest growth in terms of revenue, owing to increase in number of patients suffering from chronic diseases, and rise in government initiatives for the improvement of healthcare facilities in the region.
Global Nerve Repair & Regeneration Market Segmentation:
Global nerve repair & regeneration market segmentation by surgery:
- Direct Neuropathy
- Epineural Repair
- Perineural Repair
- Group Fascicular Repair
- Nerve Grafting
- Autografts
- Allografts
- Xenografts
- Stem Cell Therapy
- Neuromodulation Surgery
- External Neuromodulation Surgery
- Internal Neuromodulation Surgery
Global nerve repair & regeneration market segmentation by product:
- Biomaterials
- Nerve Conduits
- Nerve Protectors
- Nerve Wraps
- Nerve Connectors
- Neuromodulation Surgery Devices
- External Neuromodulation Surgery
- Internal Neuromodulation Surgery
Global nerve repair & regeneration market segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Direct Neuropathy
-
- AxoGen Inc.
- Baxter International
- Boston Scientific Incorporation
- Cyberonics Inc.
- Integra Lifesciences Corporation
- Medtronic plc
- Orthomed S.A.S.
- Polyganics B.V.
- Jude Medical
- Stryker Corporation
-
Request for TOC
-
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!